Swiss National Bank
CSTL icon

Swiss National Bank’s Castle Biosciences CSTL Stock Holding History

Swiss National Bank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
53,700
-3,600
-6% -$80.2K ﹤0.01% 2139
2026
Q1 		$1.41M Hold
57,300
– – ﹤0.01% 2019
2025
Q4 		$2.23M Buy
57,300
+1,300
+2% +$41.9K ﹤0.01% 1820
2025
Q3 		$1.28M Buy
56,000
+1,700
+3% +$34.5K ﹤0.01% 2056
2025
Q2 		$1.11M Hold
54,300
– – ﹤0.01% 2101
2025
Q1 		$1.09M Buy
54,300
+3,000
+6% +$74.3K ﹤0.01% 2091
2024
Q4 		$1.37M Hold
51,300
– – ﹤0.01% 2065
2024
Q3 		$1.46M Hold
51,300
– – ﹤0.01% 2030
2024
Q2 		$1.12M Buy
51,300
+1,100
+2% +$24.5K ﹤0.01% 2120
2024
Q1 		$1.11M Hold
50,200
– – ﹤0.01% 2163
2023
Q4 		$1.08M Sell
50,200
-5,000
-9% -$88K ﹤0.01% 2197
2023
Q3 		$932K Hold
55,200
– – ﹤0.01% 2280
2023
Q2 		$757K Buy
55,200
+6,800
+14% +$138K ﹤0.01% 2438
2023
Q1 		$1.1M Sell
48,400
-5,500
-10% -$134K ﹤0.01% 2196
2022
Q4 		$1.27M Buy
53,900
+1,000
+2% +$23.2K ﹤0.01% 2201
2022
Q3 		$1.38M Buy
52,900
+2,100
+4% +$58.9K ﹤0.01% 2131
2022
Q2 		$1.11M Buy
50,800
+2,900
+6% +$67.4K ﹤0.01% 2302
2022
Q1 		$2.15M Buy
47,900
+3,600
+8% +$149K ﹤0.01% 1999
2021
Q4 		$1.9M Hold
44,300
– – ﹤0.01% 2099
2021
Q3 		$2.95M Buy
44,300
+600
+1% +$42.2K ﹤0.01% 1796
2021
Q2 		$3.21M Buy
43,700
+2,300
+6% +$152K ﹤0.01% 1795
2021
Q1 		$2.83M Buy
41,400
+500
+1% +$37.6K ﹤0.01% 1800
2020
Q4 		$2.75M Buy
40,900
+14,800
+57% +$802K ﹤0.01% 1731
2020
Q3 		$1.34M Buy
26,100
+500
+2% +$22.2K ﹤0.01% 1922
2020
Q2 		$965K Buy
+25,600
New +$875K ﹤0.01% 2126

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss National Bank's CSTL Position: Q2 2026 in Review

Swiss National Bank reduced its Castle Biosciences (CSTL) stake by 6.3% in Q2 2026, selling an estimated $80.2K and leaving 53,700 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2139.

Swiss National Bank first reported a position in CSTL in Q2 2020 and has held it in 25 quarters since. The position peaked at $3.21M in Q2 2021. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Swiss National Bank held 53,700 shares of Castle Biosciences worth $1.28M as of Q2 2026.
  • Swiss National Bank sold 3,600 Castle Biosciences shares in Q2 2026, an estimated $80.2K.
  • Castle Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2139 holding.
  • Swiss National Bank first reported a position in Castle Biosciences in Q2 2020 and has held it in 25 quarters since.
  • Swiss National Bank's Castle Biosciences position peaked at $3.21M in Q2 2021.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.